同源康医药-B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02410 同源康医药-B

休市中 02-20 16:08:38

12.980

+0.220

+1.72%

最高12.980	最低12.700	成交量6.75万
今开12.760	昨收12.760	日振幅2.19%
总市值49.33亿	流通市值48.73亿	总股本3.80亿
成交额86.30万	换手率0.02%	流通股本3.75亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康医药-B","latestPrice":12.98,"timestamp":1771574918006,"preClose":12.76,"halted":0,"volume":67457,"delay":0,"changeRate":0.01724137931034488,"floatShares":375457818,"shares":380065818,"eps":-1.2983687039891205,"marketStatus":"休市中","change":0.22,"latestTime":"02-20 16:08:38","open":12.76,"high":12.98,"low":12.7,"amount":863004,"amplitude":0.021944,"askPrice":12.98,"askSize":5500,"bidPrice":12.72,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":-0.874392849954669,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771810200000},"marketStatusCode":7,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":12.76,"openAndCloseTimeList":[[1771551000000,1771560000000],[1771563600000,1771574400000]],"volumeRatio":0.05144072462508217,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02410","defaultTab":"news","newsList":[{"id":"2612243314","title":"每日卖空追踪 | 同源康医药-B 02月16日卖空量成交1500股，卖空比例为1.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612243314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612243314?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230627,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月16日，跌0.31%，卖空量成交1500股，较上一交易日减少94.12%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163339a4a9f7a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163339a4a9f7a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02410","BK1515","09939","BK1161"],"gpt_icon":0},{"id":"2611815925","title":"每日卖空追踪 | 同源康医药-B 02月13日卖空量成交1.3万股，卖空比例为1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611815925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611815925?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:30","pubTimestamp":1770971432,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月13日，涨1.03%，卖空量成交1.3万股，较上一交易日增加333.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163438a49ff9e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163438a49ff9e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02410","09939","BK1574","BK1515"],"gpt_icon":0},{"id":"2611137547","title":"同源康医药-B02月13日主力净流入76.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2611137547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611137547?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:15","pubTimestamp":1770970526,"startTime":"0","endTime":"0","summary":"02月13日, 同源康医药-B股价涨1.03%，报收12.80元，成交金额1435.5万元，换手率0.30%，振幅2.37%，量比0.48。同源康医药-B今日主力资金净流入76.5万元，上一交易日主力净流出86.9万元。该股近5个交易日下跌0.47%，主力资金累计净流出288.0万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出827.2万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213161647a49fe5ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213161647a49fe5ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","02410","BK1515","BK1161"],"gpt_icon":0},{"id":"2610945167","title":"同源康医药-B(02410)：联交所就实施H股全流通授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2610945167","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610945167?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:07","pubTimestamp":1770887224,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)公布，公司已向联交所上市委员会申请批准公司根据转换公司1名股东持有的460.8万股非上市股份转换的460.8万股H股上市及买卖经转换H股。联交所已于2026年2月11日授出上市批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404690.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","09939","BK1161","BK1515","02410","BK1574"],"gpt_icon":0},{"id":"2610961373","title":"每日卖空追踪 | 同源康医药-B 02月11日卖空量成交7000股，卖空比例为0.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610961373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610961373?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:30","pubTimestamp":1770798633,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月11日，跌1.41%，卖空量成交7000股，较上一交易日减少81.08%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163427a6ee1e74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163427a6ee1e74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1574","02410","09939"],"gpt_icon":0},{"id":"2610605754","title":"同源康医药-B02月10日遭主力抛售93.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610605754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610605754?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:16","pubTimestamp":1770711368,"startTime":"0","endTime":"0","summary":"02月10日, 同源康医药-B股价跌0.78%，报收12.76元，成交金额2489.9万元，换手率0.51%，振幅3.89%，量比0.87。同源康医药-B今日主力资金净流出93.1万元，上一交易日主力净流出134.1万元。该股近5个交易日上涨3.24%，主力资金累计净流出3.5万元；近20日主力资金累计净流出211.7万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210162335a492ad01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210162335a492ad01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02410","BK1515","09939"],"gpt_icon":0},{"id":"2609856571","title":"同源康医药-B(02410)：甲磺酸艾多替尼片（TY-9591片）的新药上市申请获国家药品监督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2609856571","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609856571?lang=zh_cn&edition=full","pubTime":"2026-02-06 17:02","pubTimestamp":1770368535,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B 发布公告，本公司在研1类新药甲磺酸艾多替尼片的新药上市申请被国家药品监督管理局药品审评中心受理。甲磺酸艾多替尼片作为奥希替尼的氘代化合物，无论是从化学结构、药理作用、临床有效性和安全性、以及耐药机制分析，甲磺酸艾多替尼片都显示出更明显的临床价值和优势，对疾病的预后有明显改善作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402563.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1515","TY","BK1574","02410","09939","BK1161"],"gpt_icon":0},{"id":"2609786559","title":"港股异动 | 同源康医药-B(02410)午后涨近5% 甲磺酸艾多替尼片获纳入优先审评品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2609786559","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609786559?lang=zh_cn&edition=full","pubTime":"2026-02-06 14:19","pubTimestamp":1770358758,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B(02410)午后涨近5%，截至发稿，涨3.65%，报13.06港元，成交额2890.62万港元。消息面上，同源康医药此前公布，公司在研1类新药甲磺酸艾多替尼片(TY-9591片)被国家药品监督管理局(NMPA)药品审评中心(CDE)纳入优先审评品种名单。据悉，该药物拟用于治疗具有表皮生长因子受体(EGFR)外显子19缺失或外显子21置换突变，并伴有中枢神经系统转移的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的一线治疗。此次被纳入优先评审，标志着甲磺酸艾多替尼片的审评进程将全面提速，有望更早上市，为中国患者提供新的治疗选择。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1574","VXUS","BK1515","02410","BK1161","BK4588","VT","BK4585","09939"],"gpt_icon":0},{"id":"2608986043","title":"每日卖空追踪 | 同源康医药-B 02月04日卖空量成交500股，卖空比例为0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608986043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608986043?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:30","pubTimestamp":1770193830,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月04日，涨0.08%，卖空量成交500股，较上一交易日减少80%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163637a6d20465&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163637a6d20465&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1515","02410","09939"],"gpt_icon":0},{"id":"1110153215","title":"浙江同源康医药（2410）1月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1110153215","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110153215?lang=zh_cn&edition=full","pubTime":"2026-02-03 17:36","pubTimestamp":1770111387,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司（02410）于2026年2月3日披露截至2026年1月31日的股份变动月报表。公告显示，公司当月未有新增发行、购回或注销等股份变动事宜，股本结构维持稳定。\n公司注册股本总计为人民币380,065,818元，其中H股股份数为375,457,818股，非上市股份数为4,608,000股。本月报表显示，上述H股与非上市股份数量均无增减，分别保持在375,457,818股和4,608,000股。\n根据公告，公司确认当前符合香港联交所主板上市规则所要求的公众持股量规定，且并无股份期权、股权激励计划或可转换债券等相关变动。月报由执行董事、董事长兼总裁吴豫生签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"gpt_icon":0},{"id":"2608850786","title":"每日卖空追踪 | 同源康医药-B 02月02日卖空量成交9000股，卖空比例为0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608850786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608850786?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:30","pubTimestamp":1770021030,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月02日，跌3%，卖空量成交9000股，较上一交易日减少50%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163651a6c985c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163651a6c985c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","09939","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"2608713850","title":"同源康医药-B02月02日遭主力抛售50.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608713850","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608713850?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:15","pubTimestamp":1770020129,"startTime":"0","endTime":"0","summary":"02月02日, 同源康医药-B股价跌3.00%，报收12.27元，成交金额3124.7万元，换手率0.67%，振幅6.09%，量比0.58。同源康医药-B今日主力资金净流出50.3万元，连续5日净流出，上一交易日主力净流出65.1万元。该股近5个交易日下跌3.39%，主力资金累计净流出742.7万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入427.8万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202161753a6c97173&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202161753a6c97173&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","09939","02410","BK1574"],"gpt_icon":0},{"id":"2607306694","title":"港股异动 | 同源康医药-B(02410)早盘涨超13% 甲磺酸艾多替尼片获纳入优先审评品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2607306694","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607306694?lang=zh_cn&edition=full","pubTime":"2026-01-30 09:35","pubTimestamp":1769736942,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B(02410)早盘涨超13%，截至发稿，涨8.94%，报13.52港元，成交额4070.33万港元。消息面上，同源康医药公布，公司在研1类新药甲磺酸艾多替尼片(TY-9591片)被国家药品监督管理局(NMPA)药品审评中心(CDE)纳入优先审评品种名单。据悉，该药物拟用于治疗具有表皮生长因子受体(EGFR)外显子19缺失或外显子21置换突变，并伴有中枢神经系统转移的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的一线治疗。此次被纳入优先评审，标志着甲磺酸艾多替尼片的审评进程将全面提速，有望更早上市，为中国患者提供新的治疗选择。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399541.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","BK1161","VT","BK1574","BK4588","BK4585","09939","BK1515","02410"],"gpt_icon":0},{"id":"1193030035","title":"同源康医药-B旗下阿散德替尼获国家药监局药品审评中心纳入优先审评品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=1193030035","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193030035?lang=zh_cn&edition=full","pubTime":"2026-01-29 17:16","pubTimestamp":1769678166,"startTime":"0","endTime":"0","summary":"同源康医药股份有限公司宣布，其研发的阿散德替尼（Asandeutertinib）已被中国国家药品监督管理局药品审评中心正式纳入优先审评品种名单。这一重要进展标志着该药物在临床价值和市场潜力方面获得了监管机构的高度认可。\n优先审评资格的获得，将有望显著缩短阿散德替尼的审评审批时间，加速其在中国市场的上市进程，从而惠及更多患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02410"],"gpt_icon":0},{"id":"2607702571","title":"同源康医药-B(02410)在研1类新药甲磺酸艾多替尼片被国家药品监督管理局药品审评中心纳入优先审评品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2607702571","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607702571?lang=zh_cn&edition=full","pubTime":"2026-01-29 17:08","pubTimestamp":1769677696,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)公布，公司在研1类新药甲磺酸艾多替尼片(TY-9591片)被国家药品监督管理局(NMPA)药品审评中心(CDE)纳入优先审评品种名单。甲磺酸艾多替尼片(TY-9591片)拟定的适应症为具有EGFR外显子19缺失(19DEL) 或外显子21(L858R)置换突变，并伴有CNS转移的局部晚期或转移性NSCLC成人患者的一线治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399178.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02410","BK1515","BK1574","BK1161","159938","09939"],"gpt_icon":0},{"id":"2607037664","title":"每日卖空追踪 | 同源康医药-B 01月29日卖空量成交7.9万股，卖空比例为3.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607037664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607037664?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:30","pubTimestamp":1769675432,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间01月29日，跌0.32%，卖空量成交7.9万股，较上一交易日增加558.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164013a6bae324&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164013a6bae324&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1515","02410","09939"],"gpt_icon":0},{"id":"2607348777","title":"每日卖空追踪 | 同源康医药-B 01月28日卖空量成交9500股，卖空比例为0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607348777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607348777?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:30","pubTimestamp":1769589030,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间01月28日，跌0.32%，卖空量成交9500股，较上一交易日增加72.73%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164835a45f8ca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164835a45f8ca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1574","BK1161","BK1515","09939"],"gpt_icon":0},{"id":"2607777322","title":"同源康医药-B01月28日遭主力抛售296.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607777322","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607777322?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:15","pubTimestamp":1769588144,"startTime":"0","endTime":"0","summary":"01月28日, 同源康医药-B股价跌0.32%，报收12.45元，成交金额6944.1万元，换手率1.53%，振幅2.56%，量比2.80。同源康医药-B今日主力资金净流出296.9万元，上一交易日主力净流出205.1万元。该股近5个交易日下跌4.23%，主力资金累计净流出484.1万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入1069.9万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162144a6b66ca9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162144a6b66ca9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","02410","BK1161","09939"],"gpt_icon":0},{"id":"2605474003","title":"同源康医药-B(02410)：中国证监会发出关于公司申请H股全流通的备案通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2605474003","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605474003?lang=zh_cn&edition=full","pubTime":"2026-01-23 19:48","pubTimestamp":1769168893,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)发布公告，近日中国证监会已就H股全流通向公司发出备案通知书。根据备案通知书，有关公司1名股东持有460.8万股非上市股份转换为460.8万股H股的H股全流通的中国证监会备案已告完成。于完成有关转换及联交所授予上市批准后，该等460.8万股H股将于联交所主板上市及买卖。备案通知书将自中国证监会核准之日起12个月内有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396845.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02410","BK1161","09939","BK1515","159938"],"gpt_icon":0},{"id":"2605474423","title":"同源康医药-B(02410)获浙江省药品监督管理局颁发《药品生产许可证》","url":"https://stock-news.laohu8.com/highlight/detail?id=2605474423","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605474423?lang=zh_cn&edition=full","pubTime":"2026-01-23 19:27","pubTimestamp":1769167677,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)公布，公司获浙江省药品监督管理局颁发的《药品生产许可证》。本次获得药品生产许可证，预期将对公司扩大产能及拓展市场产生长远的积极作用，为后续开展商业化生产奠定基础，有望早日为患者提供更好的治疗选择，以满足癌症治疗中亟待满足的医疗需求。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","159938","09939","BK1515","02410","BK1161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":-0.0023},{"period":"3month","weight":0.0587},{"period":"6month","weight":-0.1748},{"period":"1year","weight":-0.5593},{"period":"ytd","weight":-0.0099}],"compareEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":-0.0065},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0424},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0305}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。该公司专注于小分子药物开发，其主要产品包括TY-9591、TY-302和TY-2136。TY-9591是一种第三代EGFR-TKI，对EGFR突变具有抗肿瘤作用。TY-302是一种为治疗乳腺癌及前列腺癌等晚期实体瘤而开发的强效、选择性口服CDK4/6抑制剂。TY-2136b为自主研发、口服ROS1/NTRK抑制剂，用于治疗实体瘤。","exchange":"SEHK","name":"同源康医药-B","nameEN":"TYK MEDICINES-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"同源康医药-B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供同源康医药-B(02410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"同源康医药-B,02410,同源康医药-B股票,同源康医药-B股票老虎,同源康医药-B股票老虎国际,同源康医药-B行情,同源康医药-B股票行情,同源康医药-B股价,同源康医药-B股市,同源康医药-B股票价格,同源康医药-B股票交易,同源康医药-B股票购买,同源康医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"同源康医药-B(02410)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供同源康医药-B(02410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}